(Q45306804)

11 December 2017

title

Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea (English)

1 reference

11 December 2017

0 references

Perry TL

1

1 reference

11 December 2017

Hansen S

series ordinal

2

1 reference

11 December 2017

Wall RA

series ordinal

3

1 reference

11 December 2017

Gauthier SG

series ordinal

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 1982

1 reference

Journal of Neurochemistry

11 December 2017

published in

1 reference

11 December 2017

volume

38

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

766-773

1 reference

O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Cerebrospinal fluid homocarnosine in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

2-pyrrolidinone--a cyclization product of gamma-aminobutyric acid detected in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Measurement of GABA in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

GABA levels in cerebrospinal fluid of patients with Huntington's chorea: A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

Low cerebrospinal fluid -aminobutyric acid content in seizure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1982.TB08697.X

10.1111/J.1471-4159.1982.TB08697.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference